VERIPHARM: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
VERIPHARM
Largest movements
- Current investments -€344,407
down €344,407 (-98.5%), from €349,707 to €5,300
- Tangible fixed assets -€96,826
down €96,826 (-7.4%), from €1.3m to €1.2m
of which Land and buildings: -€94,782
- Cash -€33,842
down €33,842 (-31.0%), from €109,285 to €75,443
mainly Other debts (-€570,000) and Debts after one year (-€58,011)
- Receivables within one year +€30,876
up €30,876 (+13.5%), from €228,395 to €259,271
of which Other amounts receivable: +€30,209
- Other debts -€570,000
no longer reported in 2025 (was €570,000)
- Reserves +€184,855
up €184,855 (+42.1%), from €438,875 to €623,730
of which Distributable reserves: +€184,855
- Debts after one year -€58,011
down €58,011 (-8.9%), from €652,305 to €594,294
- Financial income +€153,107
up €153,107 (+784%), from €19,538 to €172,645
of which Non-recurring financial income: +€164,087
- Taxes +€14,706
up €14,706 (+173%), from €8,497 to €23,203
- Gross operating margin +€7,750
up €7,750 (+4.8%), from €162,523 to €170,272
- Depreciation -€3,661
down €3,661 (-3.6%), from €100,488 to €96,826
- Financial charges +€3,055
up €3,055 (+12.6%), from €24,192 to €27,247
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,993,812 | €1,549,613 | -€444,199 | -22.3% |
| Fixed assets | 21/28 | €1,306,425 | €1,209,599 | -€96,826 | -7.4% |
| Tangible fixed assets | 22/27 | €1,306,425 | €1,209,599 | -€96,826 | -7.4% |
| Land and buildings | 22 | €1,290,891 | €1,196,108 | -€94,782 | -7.3% |
| Plant, machinery and equipment | 23 | €14,089 | €12,527 | -€1,562 | -11.1% |
| Furniture and vehicles | 24 | €1,446 | €964 | -€482 | -33.3% |
| Current assets | 29/58 | €687,387 | €340,014 | -€347,373 | -50.5% |
| Amounts receivable within one year | 40/41 | €228,395 | €259,271 | +€30,876 | +13.5% |
| Trade receivables | 40 | €89,555 | €90,221 | +€667 | +0.7% |
| Other amounts receivable | 41 | €138,841 | €169,050 | +€30,209 | +21.8% |
| Current investments | 50/53 | €349,707 | €5,300 | -€344,407 | -98.5% |
| Cash at bank and in hand | 54/58 | €109,285 | €75,443 | -€33,842 | -31.0% |
| Total equity and liabilities | 10/49 | €1,993,812 | €1,549,613 | -€444,199 | -22.3% |
| Equity | 10/15 | €700,375 | €885,230 | +€184,855 | +26.4% |
| Contributions | 10/11 | €261,500 | €261,500 | = | 0.0% |
| Capital | 10 | €261,500 | €261,500 | = | 0.0% |
| Issued capital | 100 | €261,500 | €261,500 | = | 0.0% |
| Reserves | 13 | €438,875 | €623,730 | +€184,855 | +42.1% |
| Non-distributable reserves | 130/1 | €26,150 | €26,150 | = | 0.0% |
| Legal reserve | 130 | €26,150 | €26,150 | = | 0.0% |
| Distributable reserves | 133 | €412,725 | €597,580 | +€184,855 | +44.8% |
| Amounts payable | 17/49 | €1,293,437 | €664,382 | -€629,054 | -48.6% |
| Amounts payable after more than one year | 17 | €652,305 | €594,294 | -€58,011 | -8.9% |
| Financial debts | 170/4 | €652,305 | €594,294 | -€58,011 | -8.9% |
| Amounts payable within one year | 42/48 | €639,952 | €68,058 | -€571,893 | -89.4% |
| Current portion of amounts payable after more than one year | 42 | €65,511 | €58,011 | -€7,500 | -11.4% |
| Trade debts | 44 | €1,644 | €1,193 | -€451 | -27.4% |
| Suppliers | 440/4 | €1,644 | €1,193 | -€451 | -27.4% |
| Taxes, remuneration and social security | 45 | €2,796 | €8,854 | +€6,058 | +217% |
| Taxes | 450/3 | €2,796 | €3,854 | +€1,058 | +37.8% |
| Remuneration and social security | 454/9 | - | €5,000 | +€5,000 | |
| Other amounts payable | 47/48 | €570,000 | - | -€570,000 | |
| Accrued charges and deferred income | 492/3 | €1,180 | €2,030 | +€850 | +72.0% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €100,488 | €96,826 | -€3,661 | -3.6% |
| Other operating charges | 640/8 | €12,694 | €10,786 | -€1,909 | -15.0% |
| Gross operating margin | 9900 | €162,523 | €170,272 | +€7,750 | +4.8% |
| Operating profit (loss) | 9901 | €49,340 | €62,660 | +€13,320 | +27.0% |
| Financial income | 75/76B | €19,538 | €172,645 | +€153,107 | +784% |
| Recurring financial income | 75 | €19,538 | €8,558 | -€10,980 | -56.2% |
| Non-recurring financial income | 76B | - | €164,087 | +€164,087 | |
| Financial charges | 65/66B | €24,192 | €27,247 | +€3,055 | +12.6% |
| Recurring financial charges | 65 | €24,192 | €27,247 | +€3,055 | +12.6% |
| Profit (loss) for the period before taxes | 9903 | €44,686 | €208,058 | +€163,372 | +366% |
| Income taxes | 67/77 | €8,497 | €23,203 | +€14,706 | +173% |
| Profit (loss) for the period | 9904 | €36,189 | €184,855 | +€148,666 | +411% |
| Profit (loss) for the period to be appropriated | 9905 | €36,189 | €184,855 | +€148,666 | +411% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 16 October 2026 via checked.be.